Farid Abedrabbo 🇪🇨

Neurologist, neurovascular enthusiast 🧠

[Farid Abedrabbo 🇪🇨 @F_Abedrabbo]

Today we broke down educational barriers at the first neurovascular symposium in Ecuador. Dear Professor @DavidSeiffge , thank you for honoring us with your time. It is a privilege to learn from you. Having you at a talk for our Ecuadorian neurology team 🇪🇨 was a true luxury.

[International Journal of Stroke @IntJStroke]

💉🧠Study finds IVT+EVT for medium distal vessel occlusions was associated with worse functional outcomes vs IVT alone

👉Supports recent research but more RCTs needed

Read more here👇
https://t.co/R5wtmHeSck

[International Journal of Stroke @IntJStroke]

🧠⏱️In patients with breakthrough ischemic stroke, early severity-adapted DOAC initiation was associated with:

⬇️Lower risks of recurrent ischemic events & mortality at 90 days
❌No increase in major bleeding

https://t.co/CYSAm4UbTa @luciodanna2 @Simona_Sacco_ @mattfos89

[International Journal of Stroke @IntJStroke]

🤰🧠New review of stroke in pregnancy is now available

🩸Physiological mechanisms impacting stroke risk include hypercoagulability, inflammation and hemodynamic changes

Read the review here!👇
https://t.co/ZycQjsqzT1

[Stroke AHA/ASA @StrokeAHA_ASA]

GLP-1 Receptor Agonists for Nondiabetic Ischemic Stroke: Compelling Biology, But Uncertain Clinical Benefit, Yet

In this #BloggingStroke post, @romilsingh1892 discusses #Stroke article by Michaelsen et al. @clauszsimonsen @rablauenfeldt @svartmads https://t.co/f5AnFIeuPe

[International Journal of Stroke @IntJStroke]

✅🔎HERMES-24 score shows excellent prediction of 90-day outcomes after EVT across LVO localization and treatment windows in real-world patients

Read more here! 👇
https://t.co/TQVBqSXBHO

[International Journal of Stroke @IntJStroke]

#FlashbackFriday !
📊Secondary analysis of CONVINCE
🧠💊Regardless of stroke subtype, direction of effect for prevention of recurrent major adverse cardiovascular events favoured colchicine

Read more here👇
https://t.co/sgbVfuN8O2

[Stroke AHA/ASA @StrokeAHA_ASA]

When Is Early Too Late? Timing Matters for Dual Antiplatelet Therapy After Minor Stroke and TIA

In this #BloggingStroke post, Anel Karisik discusses #Stroke article by Shin et al. @KimBJstroke @doohyuk_kwon https://t.co/ldK45rV54p

[Amit Chaudhari MD @NeuroIRdoc]

"Most imaging biomarkers are predictors of outcome rather treatment effect modifiers. Therefore, these techniques should not be used primarily to exclude patients from thrombectomy,” Nogueira clarified."

YESSSS!
https://t.co/Z62tKQCQFd.

[Stroke AHA/ASA @StrokeAHA_ASA]

Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association https://t.co/Se66kc7eBp

[International Journal of Stroke @IntJStroke]

📊Study finds early hematoma absorption is common after ICH and associated with favorable early neurological evolution

🎯May represent an endogenous hematoma resolution process and potential therapeutic target

Read more below👇
https://t.co/n7y25lgi1P @QiLiMD

[Continuum: Lifelong Learning in Neurology @ContinuumAAN]

Key Point 4 from the article Stroke in Children and Younger Adults by Drs. Thalia S. Field and Thiviya Selvanathan from the June #CerebrovascularDisease issue, which is available to subscribers at https://t.co/AIti3AZLUq. #NeuroTwitter #MedEd

[International Journal of Stroke @IntJStroke]

🤔Rethinking stroke trials
☝️📊Advances in trial design and outcome assessment may improve efficiency, interpretability, and clinical relevance of stroke trials

Read the review here!⬇️
https://t.co/vyYHTjILmI

[AHA Science @AHAScience]

Building on the First Definition of Heart Failure, the Second Definition refines HF staging with sharper stage criteria, emphasizing early detection and individualized risk reduction and introduces the universal classification of HF causes, with explicit acknowledgment of geographic variation in HF risk and outcomes. https://t.co/YDuE4stb5s

This updated document provides a unified, internationally harmonized framework intended to standardize terminology. It addresses changes in disease manifestations, diagnostic strategies, and understanding of pathophysiology.

✍🏼 @MinnowWalsh @KarenSliwa @amibanerjee1 @BiykemB @akshaydesaimd @DukeHFDoc @MKIttlesonMD @lamcardio @WilfriedMullens @NutritionHF

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: In a multicenter cohort of patients with dAVF, hemorrhagic presentation was primarily determined by venous anatomy, with high-grade dAVFs and male sex independently increasing risk, while antithrombotic therapy showed a protective association. https://t.co/MX23E2cjro

[Farid Abedrabbo 🇪🇨 @F_Abedrabbo]

As a Ecuadorian I feel completely honored to be able to learn the path of neurovascular neurology from these brilliant minds. Being part of this program is motivation to improve access to treatment for our people. Immensely grateful @MASStroke @ESOstroke

[Farid Abedrabbo 🇪🇨 @F_Abedrabbo]

Oxford-style debate winners!! These have undoubtedly been exceptional days of learning; I'm truly delighted with the level of teaching of the @MASStroke @ESOstroke 🧠🧠🧠🧠

[Farid Abedrabbo 🇪🇨 @F_Abedrabbo]

Thank you for revolutionizing the field of neurovascular neurology and for being role models for those of us who want to follow in your footsteps. @FishingNeurons @DavidSeiffge @ESOstroke @MASStroke

[Shadi Yaghi @ShadiYaghi2]

TCD with bubble has the highest sensitivity to detect a right to left shunt and TEE with bubble has the highest specificity to diagnose a PFO. Cardiac CT has low sensitivity for PFO. Great work by @nbavar https://t.co/Ei4eLqqEoB

[Stroke AHA/ASA @StrokeAHA_ASA]

🧵 ICYMI: May #Stroke Highlights:

🌟 Among patients with isolated vertebral artery occlusion, IVT improved recanalization without outcome benefit, while EVT ± IVT showed worse outcomes, with higher ICH and mortality rates.

[International Journal of Stroke @IntJStroke]

#FlashbackFriday !
🧠💉In acute ischemic stroke patients with anterior-circulation LVO, IV tirofiban administration following EVT:
⬆️Improved favorable functional outcomes
❌Did not increase the risk of sICH or END

Read more below!👇
https://t.co/qQHxv05Ghw @linaazheng